RSS   Newsletter   Contact   Advertise with us
Post Online Media

Oncolytics Biotech names Andres A. Gutierrez as CMO

Oncolytics BiotechOncolytics Biotech, a clinical stage biotechnology company, announced the appointment of Andres A. Gutierrez to the role of chief medical officer.
Article continues below

READ MORE Oncolytics announces addition to senior management team

Dr. Gutierrez is board certified in internal medicine and completed a fellowship in medical oncology.

Dr. Gutierrez has held progressively senior clinical development positions designing and implementing both early and later-stage oncology clinical studies at a range of U.S. and European companies including Sellas Life Sciences Group, Bristol-Myers Squibb, Sunesis Pharmaceuticals Inc, Biomarin Pharmaceutical Inc, Proteolix, and Oculus Innovative Sciences.

Prior to that, Dr. Gutierrez held a series of academic and consulting positions. Over his 32 year career, he has authored and co-authored more than 90 peer-reviewed publications and abstracts and presented at numerous conferences.

Dr. Gutierrez received his MD and a PhD in Biomedical Sciences from the National Autonomous University of Mexico.



We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy